Publication | Closed Access

Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis

EngineeringBiochemistryMalignant DiseaseTheranosticsInactive ChemotherapeuticsTumor TargetingChemodynamic TherapyAnti-cancer AgentPlatinum–bisphosphonate ComplexesCancer TreatmentOncologyRadiation OncologyInappropriate HydrolysisCancer ResearchBiomolecular EngineeringHealth Sciences